In May this year, when Covid cases started surging once again in India, SII CEO Adar Poonawalla had said that the SII will continue to scal...

The head of the GAVI Vaccine Alliance, which sponsors the COVAX programme along with the World Health Organisation, Unicef and the Coalitio...

Speaking in Berlin at the opening of a new epidemic intelligence hub, Director-General Tedros Adhanom Ghebreyesus urged countries with spar...

Known as COVAX, the program was supposed to be a global powerhouse, a multibillion-dollar alliance of international health bodies and nonpr...

Gavi, the Vaccine Alliance, says it now projects that the COVAX program can supply just under 1.9 billion doses this year -- including abou...

“Keeping in view the domestic demand, we will not be able to supply doses to the Covax facility till the situation improves in India,” a se...

COVAX, "the global COVID vaccine equity scheme", has so far delivered 65 million doses to 124 countries and economies but it is dependent o...

COVAX, which supplies doses to poorer countries, relies heavily on India's Serum Institute's exports of the AstraZeneca shot but many of th...

The global programme - co-led by the GAVI vaccine alliance and the World Health Organization (WHO) - said that while it was hoping to resta...

Despite pledging billions of dollars for the scheme set up by the World Health Organization (WHO) and publicly endorsing it, European Union...

"We applaud the other countries who have made and delivered pledges, which have put us on track to meet Gavi's initial goal to deliver vacc...

Several Asian countries scrambled to find alternative sources for COVID-19 inoculations on Tuesday after export restrictions by manufacture...

The AstraZeneca-Oxford vaccine is being produced under licence in India for the Covax scheme, also led by GAVI, which is meant to ensure th...

AstraZeneca doses produced under licence in India form the overwhelming bulk of vaccines that COVAX has been anticipating for the initial m...

Vaccines that have not undergone a bridging trial will not be accepted, a senior government official told ET. A bridging trial is a study c...

The global health body has warned that such deals were driving up vaccine prices and could delay the launch of COVAX, an initiative aimed a...

COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income level, annou...